Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Berger

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|December 6, 2016
Comparison of Liver Cell Models Using the Basel Phenotyping CocktailBenjamin Berger, Massimiliano Donzelli, Swarna Maseneni, et al.
BMC Neurology|February 3, 2016
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresisBenjamin Berger, Tilman Hottenrott, Jonas Leubner, et al.
The Journal of Infectious Diseases|March 17, 2018
Pathological Cerebrospinal Fluid Findings in Patients With Neuralgic Amyotrophy and Acute Hepatitis E Virus InfectionMiriam Fritz, Benjamin Berger, Mathias Schemmerer, et al.
Clinical and Translational Science|April 12, 2023
Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT-1014-6470 in vitro and in vivoMarion Anliker-Ort, Jasper Dingemanse, Stephane Delahaye, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2025
The orexin 1-selective receptor antagonist nivasorexant is a time-dependent inhibitor of CYP2C19 and CYP3A4Alexander Treiber, Fabienne Drouet, Swen Seeland, et al.
Journal of Affective Disorders|March 28, 2016
Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromesDominique Endres, Evgeniy Perlov, Rick Dersch, et al.
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adultsClaudia Suenderhauf, Benjamin Berger, Maxim Puchkov, et al.
Journal of the Neurological Sciences|January 1, 2013
Early blood-based microbiological testing is ineffective in severe stroke patientsChristoph Gumbinger, Andreas Hug, Bettina Mürle, et al.
BMC Neurology|February 2, 2018
The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.
Neuro-Oncology|May 28, 2010
Defective p53 antiangiogenic signaling in glioblastomaBenjamin Berger, David Capper, Dieter Lemke, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|December 6, 2016
Comparison of Liver Cell Models Using the Basel Phenotyping CocktailBenjamin Berger, Massimiliano Donzelli, Swarna Maseneni, et al.
BMC Neurology|February 3, 2016
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresisBenjamin Berger, Tilman Hottenrott, Jonas Leubner, et al.
The Journal of Infectious Diseases|March 17, 2018
Pathological Cerebrospinal Fluid Findings in Patients With Neuralgic Amyotrophy and Acute Hepatitis E Virus InfectionMiriam Fritz, Benjamin Berger, Mathias Schemmerer, et al.
Clinical and Translational Science|April 12, 2023
Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT-1014-6470 in vitro and in vivoMarion Anliker-Ort, Jasper Dingemanse, Stephane Delahaye, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2025
The orexin 1-selective receptor antagonist nivasorexant is a time-dependent inhibitor of CYP2C19 and CYP3A4Alexander Treiber, Fabienne Drouet, Swen Seeland, et al.
Journal of Affective Disorders|March 28, 2016
Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromesDominique Endres, Evgeniy Perlov, Rick Dersch, et al.
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adultsClaudia Suenderhauf, Benjamin Berger, Maxim Puchkov, et al.
Journal of the Neurological Sciences|January 1, 2013
Early blood-based microbiological testing is ineffective in severe stroke patientsChristoph Gumbinger, Andreas Hug, Bettina Mürle, et al.
BMC Neurology|February 2, 2018
The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.
Neuro-Oncology|May 28, 2010
Defective p53 antiangiogenic signaling in glioblastomaBenjamin Berger, David Capper, Dieter Lemke, et al.
Pageof 7